Plasma Amino Acid Response to Whey Protein Ingestion Following 28-days of Probiotic Supplementation
NCT ID: NCT04491188
Last Updated: 2020-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2018-01-08
2018-05-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Probiotic Supplementation on Markers of Muscle Damage and Performance Following Exercise Induced Muscle Damage
NCT02520583
Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness
NCT07219498
Immune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance Exercise
NCT04441840
the Role of Probiotic in Protein Metabolism
NCT06307821
Safety and Efficacy of a Probiotic Supplement
NCT05425329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotic
1 x10-9 CFU Bacillus subtilis DE111 was consumed daily for 28-days
Bacillus subtilis DE111
1 x10-9 CFU Bacillus subtilis DE111 probiotic
Placebo
Maltodextrin placebo was consumed for 28-days
Placebo
Maltodextrin placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bacillus subtilis DE111
1 x10-9 CFU Bacillus subtilis DE111 probiotic
Placebo
Maltodextrin placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Free of any physical limitations, medications, and supplements that may affect performance, as determined by a health and activity questionnaire.
* Are free of musculoskeletal injuries
* Are not taking medications that may interfere with study measurements
Exclusion Criteria
* Any chronic illness that causes continuous medical care
* Taking any other nutritional supplement or performance enhancing drug.
* Any chronic illness that causes continuous medical care.
18 Years
34 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deerland Enzymes
INDUSTRY
Lipscomb University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeremy Townsend
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jeremy Townsend
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01082018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.